Clover Health Investments, Corp. (CLOV)
Company Info
Highlights
$1.69B
-$0.09
$1.02B
$283.04M
-$22.08M
$0.79 - $4.87
$4.75
3.06%
2.15
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Clover Health Investments, Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Clover Health Investments, Corp. (CLOV) returned 19.05% year-to-date (YTD) and 330.74% over the past 12 months.
CLOV
19.05%
8.07%
2.18%
330.74%
N/A
N/A
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of CLOV, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 39.37% | -9.57% | -9.57% | -5.29% | 10.29% | 19.05% | |||||||
| 2024 | 0.64% | -9.84% | -8.09% | -20.65% | 74.60% | 11.82% | 55.28% | 37.70% | 7.22% | 46.10% | -15.53% | -9.48% | 230.85% |
| 2023 | 43.09% | -0.75% | -35.98% | -12.60% | 14.66% | 5.93% | 39.34% | 4.80% | -17.56% | -11.73% | -3.39% | 3.38% | 2.43% |
| 2022 | -30.65% | 5.43% | 30.51% | -24.23% | -0.74% | -19.85% | 30.84% | -6.79% | -34.87% | -7.06% | -17.09% | -29.05% | -75.01% |
| 2021 | -16.82% | -32.62% | -19.57% | 30.29% | -22.44% | 74.35% | -39.41% | 7.71% | -13.87% | 1.49% | -33.87% | -25.00% | -77.53% |
| 2020 | 9.61% | -5.63% | -0.47% | 18.67% | -19.58% | 3.69% | 61.41% | 64.41% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 99, CLOV is among the top 1% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Clover Health Investments, Corp. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 2.69% |
Monthly Dividends
The table displays the monthly dividend distributions for Clover Health Investments, Corp.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.10 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Clover Health Investments, Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Clover Health Investments, Corp. was 97.16%, occurring on Apr 17, 2024. The portfolio has not yet recovered.
The current Clover Health Investments, Corp. drawdown is 82.85%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.16% | Jun 9, 2021 | 719 | Apr 17, 2024 | — | — | — |
| -60.05% | Dec 29, 2020 | 96 | May 17, 2021 | 15 | Jun 8, 2021 | 111 |
| -24.35% | Sep 30, 2020 | 32 | Nov 12, 2020 | 26 | Dec 21, 2020 | 58 |
| -7.48% | Jul 13, 2020 | 29 | Aug 20, 2020 | 15 | Sep 11, 2020 | 44 |
| -7.24% | Sep 21, 2020 | 4 | Sep 24, 2020 | 3 | Sep 29, 2020 | 7 |
Volatility
Volatility Chart
The current Clover Health Investments, Corp. volatility is 16.32%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Clover Health Investments, Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Clover Health Investments, Corp., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 23.1% positive surprise.
Valuation
The Valuation section provides an overview of how Clover Health Investments, Corp. is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CLOV relative to other companies in the Healthcare Plans industry. Currently, CLOV has a P/S ratio of 1.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CLOV in comparison with other companies in the Healthcare Plans industry. Currently, CLOV has a P/B value of 5.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |